Opera-1 Trial: Interim Analysis of Safety and Antiviral Activity of Tmc435 in Treatment-naive Genotype 1 Hcv Patients

DIAL.pr - BOREAL

Primary tabs

Authors	:	Manns, M. Horsmans, Yves [UCL] Reesink, H. Moreno, C. Berg, T. Benhamou, Y. Dusheiko, G. Flisiak, R. Meyvisch, P. Lenz, O. Sekar, V. van't Klooster, G. Simmen, K. Verloes, R. et al.[show all]
Document type	:	Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection
Access type	:	Accès restreint
Publication date	:	2009
Language	:	Anglais
Conference	:	"44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver", Copenhagen (Denmark) (Apr 22-26, 2009)
Journal information	:	"Journal of Hepatology" - Vol. 50, p. S7-S7 (2009)
Peer reviewed	:	yes
issn	:	0168-8278
e-issn	:	1600-0641
Publisher	:	Elsevier Science Bv (Amsterdam)
Affiliations	:	UCL - Cliniques universitaires Saint-Luc UCL
Links	:	[DOI]https://doi.org/10.1016/S0168-8278(09)60013-1 [Handle]http://hdl.handle.net/2078.1/58941

Bibliographic reference	Manns, M. ; Horsmans, Yves ; Reesink, H. ; Moreno, C. ; Berg, T. ; et. al. Opera-1 Trial: Interim Analysis of Safety and Antiviral Activity of Tmc435 in Treatment-naive Genotype 1 Hcv Patients.44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (Copenhagen (Denmark), Apr 22-26, 2009). In: Journal of Hepatology, Vol. 50, p. S7-S7 (2009)
Permanent URL	http://hdl.handle.net/2078.1/58941